<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04583202</url>
  </required_header>
  <id_info>
    <org_study_id>ALY-004</org_study_id>
    <nct_id>NCT04583202</nct_id>
  </id_info>
  <brief_title>Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber</brief_title>
  <official_title>Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alyatec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alyatec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the nasal and conjunctival response in subjects allergic&#xD;
      to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber&#xD;
      (EEC)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, single-blind, placebo-controlled study. The first part of the study&#xD;
      consists of 6 exposure sessions in Alyatec EEC, including placebo and birch pollen allergen&#xD;
      exposures.&#xD;
&#xD;
      The second part of the study involves in-field evaluations of rhinitis and conjunctivitis&#xD;
      symptoms during birch pollen season.&#xD;
&#xD;
      Alyatec environmental exposure chamber, also called allergen challenge chamber, allows to&#xD;
      evaluate allergic symptoms in standardized and reproducible conditions. All the metrological&#xD;
      parameters (temperature, air flow, hygrometry ...) are controlled as well as the allergen&#xD;
      concentration diffused in the room.&#xD;
&#xD;
      This enables to induce and observe rhinitis, conjunctivitis and asthma symptoms for up to 20&#xD;
      patients at the same time, in a reproducible way and without the potential perturbations or&#xD;
      contaminations of the natural environment.&#xD;
&#xD;
      The current study aims to get specific information about allergic symptoms induced in the&#xD;
      Alyatec EEC chamber in patients sensitized to birch pollen allergen.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 24, 2020</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">October 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Nasal Symptom Score</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To assess the nasal response during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale for rhinitis</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To evaluate the intensity of the nasal response during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Nasal Symptom Score</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To evaluate the intensity of the nasal response during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale for conjunctivitis</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To evaluate the intensity of the conjunctival response during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Ocular Symptom Score</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To evaluate the intensity of the conjunctival response during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Nasal Inspiratory Flow</measure>
    <time_frame>4 hours exposure</time_frame>
    <description>To evaluate the nasal obstruction during exposure to birch allergens compared to placebo in the ALYATEC EEC.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Allergic Rhinitis</condition>
  <condition>Allergy to Pollen</condition>
  <condition>Rhinoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>Placebo exposure</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients undergo 2 placebo exposures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Birch Pollen Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients undergo 4 allergen exposures</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exposure to placebo</intervention_name>
    <description>Patients are exposed to a placebo for 4h in the Alyatec EEC</description>
    <arm_group_label>Placebo exposure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exposure to allergen</intervention_name>
    <description>Patients are exposed to birch pollen allergens for 4h in the Alyatec EEC</description>
    <arm_group_label>Birch Pollen Exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A clinical history of allergic rhinitis to birch pollen for at least 2 consecutive&#xD;
             pollen seasons requiring the taking of a symptomatic drug with or without associated&#xD;
             asthma&#xD;
&#xD;
          -  Positive skin prick tests for birch pollen (&gt; 3 mm)&#xD;
&#xD;
          -  IgE specific to birch &gt; 0.75 kUI / L.&#xD;
&#xD;
          -  Positive unit rapid nasal provocation test for birch pollen&#xD;
&#xD;
          -  Subjects having signed informed consent&#xD;
&#xD;
          -  Subjects affiliated to a social security scheme&#xD;
&#xD;
          -  Subjects able to understand and complete the procedures related to the study&#xD;
&#xD;
          -  Women of childbearing potential should have a negative pregnancy test throughout the&#xD;
             study period with effective contraception&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Specific immunotherapy (SIT) for birch allergens for more than a month in the 3 years&#xD;
             preceding the screening&#xD;
&#xD;
          -  Current use of Specific immunotherapy for another allergen&#xD;
&#xD;
          -  Medical history of anaphylaxis following exposure to birch pollen&#xD;
&#xD;
          -  Medical history of anaphylaxis linked to another allergen in the last 6 weeks&#xD;
&#xD;
          -  Nasal polyps, nasal septum deviation or diagnosis of non-allergic rhinitis&#xD;
&#xD;
          -  Subjects allergic to indoor environmental allergens (cat allergens, mold, dust mites)&#xD;
             with - Obvious exposure to these allergens.&#xD;
&#xD;
          -  Uncontrolled allergic pathology (rhinitis, conjunctivitis)&#xD;
&#xD;
          -  Forced expiratory volume in 1 second (FEV1) &lt;70% of predicted normal values&#xD;
&#xD;
          -  Moderate to severe asthma (GINA 3 to 5)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric de Blay, Pr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alyatec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alyatec</name>
      <address>
        <city>Strasbourg</city>
        <state>Grand Est</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.alyatec.com/en/</url>
    <description>Alyatec website</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 30, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Environmental Exposure Chamber</keyword>
  <keyword>Allergen Exposure Chamber</keyword>
  <keyword>Allergen provocation test</keyword>
  <keyword>Birch pollen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

